624. Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies: Immunotherapy in T/NK Cell Lymphoma
Watch Session
644 Anti-PD-1 Antibody (Sintilimab) Plus Histone Deacetylase Inhibitor (Chidamide) for the Treatment of Refractory or Relapsed Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (r/r-ENKTL): Preliminary Results from a Prospective, Multicenter, Single-Arm, Phase Ib/II Trial (SCENT)Yan Gao, Huiqiang Huang, Xiaoxiao Wang, et al.
Swami P. Iyer, Jie Xu, Melody R. Becnel, et al.
Steven M. Horwitz, James M. Foran, Michael Maris, et al.